Vivo Ventures Fund VI, L.P.

10% owner at Sagent Pharmaceuticals, Inc.; 10% owner at AVANIR PHARMACEUTICALS

Sold, on record
$11.9M
Dollars the filings state
Form 4 sales
2
Latest Nov 4, 2015
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AVANIR PHARMACEUTICALSPlan not stated
    Jul 31, 2009 2009

    Sold 411,366 shares at $2.32 ($956k)

    Vivo Ventures Fund VI, L.P., 10% owner

    Sold 4.7% of holdings ($20.3M position)8.3M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Sagent Pharmaceuticals, Inc.Unusual
    Nov 4, 2015 +2287 days

    Sold 696,823 shares at $15.72 ($11M)

    Vivo Ventures Fund VI, L.P., 10% owner

    Sold 96.5% of holdings ($11.4M position)25,337 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Vivo Ventures Fund VI, L.P.
Source
Nov 4, 2015Nov 4, 2015Sagent Pharmaceuticals, Inc.10% ownerForm 4 sale696,823$11M96.5%UnusualSEC
Jul 31, 2009Aug 3, 2009AVANIR PHARMACEUTICALS10% ownerForm 4 sale411,366$956k4.7%Plan not statedSEC